- Stephens analyst Jeff Garro initiated Teladoc Health Inc TDOC coverage with an Equal-Weight rating and a price target of $25.
- The analyst believes TDOC is well positioned to be the bellwether digital health company due to its unique assets and scale; he provides numbers confirming TDOC as a clear virtual care leader: 80M+members, 30K+ providers, 60+ NPS, 20M+ annual visits.
- Garro adds that while the company has a strong product portfolio and a large customer base, it hasn't been able to meet lofty cross-sell expectations.
- The analyst states that TDOC's positioning is compelling, but gradual member adoption of virtual-first holistic care creates a lag from pipeline to financial impact.
- Garro thinks that BetterHelp is an incredible success story, but in the short term, it is likely that it can only grow moderately while still delivering margin expansion.
- TDOC is still growing and innovating, even at a more mature stage. The analyst expects investment in LT growth to limit margin expansion.
- Price Action: TDOC shares are trading lower by 1.60% at $25.85 on the last check Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in